20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Navigating the Pharmacokinetics of Docetaxel Anhydrous

Understanding the journey of a drug through the body – its pharmacokinetics – is fundamental to optimizing treatment efficacy and safety. For Docetaxel Anhydrous, a key chemotherapeutic agent, its pharmacokinetic profile is critical for its successful application in cancer therapy.

The absorption of Docetaxel Anhydrous is primarily achieved through intravenous administration, ensuring precise dosing that might not be feasible with oral routes. Once administered, it is distributed throughout the body, with a significant portion binding to plasma proteins, particularly alpha1 acid glycoprotein. This binding influences its distribution and elimination. The docetaxel anhydrous pharmacokinetic data reveals a multi-compartment model, indicating that the drug slowly leaves the bloodstream and peripheral tissues, contributing to its prolonged action.

Metabolism of Docetaxel Anhydrous occurs mainly in the liver, primarily mediated by the cytochrome P450 CYP3A4 and CYP3A5 enzyme systems. This metabolic process transforms the drug into various metabolites, influencing its overall activity and duration. Understanding these metabolic pathways is crucial when considering docetaxel drug interactions, as other substances affecting these enzymes can alter the drug's levels in the body.

Excretion of Docetaxel Anhydrous is predominantly through the feces, with minimal amounts excreted in the urine. This highlights the importance of liver function in the drug's elimination. For researchers and pharmaceutical companies involved in developing new cancer therapies, having access to high-purity Docetaxel Anhydrous is paramount. NINGBO INNO PHARMCHEM CO.,LTD. provides this vital API, ensuring that the scientific community can conduct thorough research into its pharmacokinetic properties and optimize its use in patient care.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Docetaxel Anhydrous in Breast Cancer Treatment: A Critical Overview

Next: The Impact of Docetaxel Anhydrous Side Effects and How to Manage Them

All Rights Reserved